Literature DB >> 16926435

Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol.

Randall J Basaraba1, Erin E Smith, Crystal A Shanley, Ian M Orme.   

Abstract

Mycobacterium tuberculosis causes a lymphatic vasculitis in the lungs of guinea pigs infected by a low-dose aerosol. This observation suggests that in addition to being a direct conduit from the lungs to the regional lymph nodes, pulmonary lymphatics are themselves sites of infection and could be the site of latent infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926435      PMCID: PMC1594862          DOI: 10.1128/IAI.00332-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection.

Authors:  Tian Tian; Joshua Woodworth; Markus Sköld; Samuel M Behar
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes.

Authors:  Valérie Abadie; Edgar Badell; Patrice Douillard; Danielle Ensergueix; Pieter J M Leenen; Myriam Tanguy; Laurence Fiette; Sem Saeland; Brigitte Gicquel; Nathalie Winter
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

3.  The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis.

Authors:  R Teitelbaum; W Schubert; L Gunther; Y Kress; F Macaluso; J W Pollard; D N McMurray; B R Bloom
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

Review 4.  Current concepts of childhood tuberculosis.

Authors:  Anna M Mandalakas; Jeffrey R Starke
Journal:  Semin Pediatr Infect Dis       Date:  2005-04

5.  Intrathoracic paediatric tuberculosis: a report of 202 cases.

Authors:  P R Pineda; A Leung; N L Muller; E A Allen; W A Black; J M FitzGerald
Journal:  Tuber Lung Dis       Date:  1993-08

Review 6.  The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

Authors:  B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; J J Starke; D A Enarson; P R Donald; N Beyers
Journal:  Int J Tuberc Lung Dis       Date:  2004-04       Impact factor: 2.373

7.  Lymphadenitis as a major element of disease in the guinea pig model of tuberculosis.

Authors:  Randall J Basaraba; Deanna D Dailey; Christine T McFarland; Crystal A Shanley; Erin E Smith; David N McMurray; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2006-02-10       Impact factor: 3.131

8.  Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

Authors:  Jennifer L Taylor; Oliver C Turner; Randall J Basaraba; John T Belisle; Kris Huygen; Ian M Orme
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 9.  What animal models can teach us about the pathogenesis of tuberculosis in humans.

Authors:  D W Smith; E H Wiegeshaus
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

10.  Necrosis of lung epithelial cells during infection with Mycobacterium tuberculosis is preceded by cell permeation.

Authors:  K M Dobos; E A Spotts; F D Quinn; C H King
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

View more
  24 in total

1.  Intralobular pulmonary lymphatic distribution in normal human lung using D2-40 antipodoplanin immunostaining.

Authors:  Marianne Kambouchner; Jean-François Bernaudin
Journal:  J Histochem Cytochem       Date:  2009-03-16       Impact factor: 2.479

Review 2.  Lymphatics in lung disease.

Authors:  Souheil El-Chemaly; Stewart J Levine; Joel Moss
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

3.  Lymphatic endothelial cells are a replicative niche for Mycobacterium tuberculosis.

Authors:  Thomas R Lerner; Cristiane de Souza Carvalho-Wodarz; Urska Repnik; Matthew R G Russell; Sophie Borel; Collin R Diedrich; Manfred Rohde; Helen Wainwright; Lucy M Collinson; Robert J Wilkinson; Gareth Griffiths; Maximiliano G Gutierrez
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

Review 4.  Inhaled drug delivery for tuberculosis therapy.

Authors:  Pavan Muttil; Chenchen Wang; Anthony J Hickey
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

Review 5.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

6.  Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Shaobin Shang; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Marcela Henao-Tamayo; Laurel Hascall-Dove; David Ackart; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Vaccine       Date:  2012-01-11       Impact factor: 3.641

7.  Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372.

Authors:  Mohamed Aiyaz; Chand Bipin; Vinay Pantulwar; Raja Mugasimangalam; Crystal A Shanley; Diane J Ordway; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2014-12       Impact factor: 3.131

8.  Aerosol infection model of tuberculosis in wistar rats.

Authors:  Sheshagiri Gaonkar; Sowmya Bharath; Naveen Kumar; V Balasubramanian; Radha K Shandil
Journal:  Int J Microbiol       Date:  2010-03-18

9.  Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs.

Authors:  Olga Gil; Ivan Díaz; Cristina Vilaplana; Gustavo Tapia; Jorge Díaz; María Fort; Neus Cáceres; Sergio Pinto; Joan Caylà; Leigh Corner; Mariano Domingo; Pere-Joan Cardona
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

10.  Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Donald R Hoff; Megan L Caraway; Elizabeth J Brooks; Emily R Driver; Gavin J Ryan; Charles A Peloquin; Ian M Orme; Randall J Basaraba; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.